Praxis Precision Medicines, Inc.
METHODS OF TREATING SUBSTANCE ABUSE DISORDER, DYSPNEA, TINNITUS, AND CHILD AND ADOLESCENT DEPRESSION

Last updated:

Abstract:

The present invention relates to methods for the treatment of substance abuse disorder, dyspnea, tinnitus, child and adolescent depression, child and adolescent suicidal ideation and behavior, and child and adolescent anxiety using etifoxine or a pharmaceutically acceptable salt thereof.

Status:
Application
Type:

Utility

Filling date:

31 Jul 2020

Issue date:

25 Aug 2022